Valeant Pharmaceuticals acquire PharmaSwiss for $480 million
California-based pharmaceuticals company Valeant Pharmaceuticals International has acquired privately-held Swiss generic drugs firm PharmaSwiss for US$480 million.
Valeant Pharmaceuticals International, Inc. announced on Monday that it has signed an agreement to acquire iNova, a private pharmaceutical group which sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Southeast Asia and South Africa.